2021-09-21
Published Date
Healthcare
Industry
122
Pages
Global Lou Gehrigs Disease Market Overview The global Lou Gehrigs Disease market is expected to reach USD XX Million by the end of year 2027 from USD XX Million from the year 2021. In the span of last two years, Lou Gehrigs Disease market has shown promising growth from both sides (Demand and Supply) and demand from end users is expected to rise continuously. It has also been observed that the Lou Gehrigs Disease market has registered XX% of growth rate during 2016-2021 and is estimated to register XX% of CAGR during the period 2021 to 2027. COVID 19 Impact on Lou Gehrigs Disease Market The COVID19 outbreak had a major impact on several industries on different levels; Some of these were border restrictions, transportation, and logistics restrictions, and worldwide bans. It also created economic uncertainty as the outbreak created a situation where both manufacturing and service industries were kept shut for very long period. Lack of availability of solution and the growing number of people infected with COVID and the uncertainty about the end of the crisis are much greater than with previous outbreaks. The pandemic has resulted in the closure of regions, border restrictions and the breakdown of transport networks. Segment Analysis of Lou Gehrigs Disease Market This study on Lou Gehrigs Disease market estimates and provides revenue growth at global, regional and country levels also, offers an overview of the latest developments in each of the sub-sectors from 2016 to 2027. For this analysis, READ Market Research has bifurcated the market of Lou Gehrigs Disease into Type Segment, Application Segment and Regional Segment. The companies mentioned in the report are: AB Science Avicena Group Biogen BrainStorm Therapeutics Covis Pharmaceutical Inc. Cytokinetics Inc. Eisai Co. Ltd. GlaxoSmithKline plc. Ionis Pharmaceuticals Inc. Mitsubishi Tanabe Pharma Corp. Neuralstem Inc. Neuraltus Pharmaceuticals Inc. Newron Pharmaceuticals S.p.A. Nutra Pharma Corp. Pharnext SAS Q-Therapeutics Inc. Note: We can also add companies which are not part of the above list One of the very important chapter of Lou Gehrigs Disease market report is competitive analysis. In this chapter, we have presented a detailed overview of the competition and have provided the market revenue of each company along with the market share. Global Lou Gehrigs Disease Market Analysis By Type Riluzole Edaravone (Radicava) In the year 2021, Riluzole segment had XX% of market share and in terms of value, the Riluzole market was valued at USD XX Million. It is expected that Riluzole will have XX% of market share by the end of year 2027 and the incremental growth from 2021 till 2027 is expected to be USD XX Million. Global Lou Gehrigs Disease Market Analysis By Application Hospital Pharmacies Retail & Online Pharmacie Hospital Pharmacies segment is expected to account for XX% of market share by the end of year 2027 from XX% in 2021. The Hospital Pharmacies segment is expected to grow at USD XX million by the end of year 2027. Regional Analysis Geographically, the global Lou Gehrigs Disease market has been categorized as North America, Europe, the Asia-Pacific, the Middle East & Africa, and South America. North America accounted Lou Gehrigs Disease market accounted for XX% of the market share in the year 2021 and register strong growth during the forecast period. However, the APAC area is experiencing significant growth due to various factors. Report Scope: Market Size: XX Million (Ask for Sample in order to view the details) CAGR: XX% Ask for Sample in order to view the details) Base Year: 2021 Forecast Period: 2022-2027 Forecast Units: Value (USD Million) Geographies Covered: North America, Europe, Asia-Pacific, Middle East & Africa, South America Frequently Asked Questions - FAQ: What will be the dynamics for the adoption of Lou Gehrigs Disease market based on Healthcare Industry Which product will contribute more to the overall market share by 2027 Which region is expected to adopt Lou Gehrigs Disease offerings at a fast rate What are the key market dynamics influencing Lou Gehrigs Disease market growth How will they turn into strengths or weaknesses of companies operating in the market space
1 Report Overview 1.1 Study Scope 1.2 Major Manufacturers Covered in This Report 1.3 Market Segment by Type 1.3.1 Global Lou Gehrigs Disease Market Size Growth Rate by Type (2022-2027) 1.3.2 Riluzole 1.3.3 Edaravone (Radicava) 1.4 Market Segment by Application 1.4.1 Global Lou Gehrigs Disease Market Share by Application (2022-2027) 1.4.2 Hospital Pharmacies 1.4.3 Retail & Online Pharmacie 1.5 Study Objectives 1.6 Years Considered 2 Global Growth Trends 2.1 Global Lou Gehrigs Disease Market Size 2.1.1 Global Lou Gehrigs Disease Revenue 2016-2027 2.1.2 Global Lou Gehrigs Disease Sales 2016-2027 2.2 Lou Gehrigs Disease Growth Rate by Regions 2.2.1 Global Lou Gehrigs Disease Sales by Regions 2016-2021 2.2.2 Global Lou Gehrigs Disease Revenue by Regions 2016-2021 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 3 Market Share by Manufacturers 3.1 Lou Gehrigs Disease Sales by Manufacturers 3.1.1 Lou Gehrigs Disease Sales by Manufacturers 2016-2021 3.1.2 Lou Gehrigs Disease Sales Market Share by Manufacturers 2016-2021 3.2 Revenue by Manufacturers 3.2.1 Lou Gehrigs Disease Revenue by Manufacturers (2016-2021) 3.2.2 Lou Gehrigs Disease Revenue Share by Manufacturers (2016-2021) 3.2.3 Global Lou Gehrigs Disease Market Concentration Ratio (CR5 and HHI) 3.3 Lou Gehrigs Disease Price by Manufacturers 3.4 Key Manufacturers Lou Gehrigs Disease Plants/Factories Distribution and Area Served 3.5 Date of Key Manufacturers Enter into Lou Gehrigs Disease Market 3.6 Key Manufacturers Lou Gehrigs Disease Product Offered 3.7 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Sales and Revenue for Each Type 4.1.1 Riluzole Sales and Revenue (2016-2021) 4.1.2 Edaravone (Radicava) Sales and Revenue (2016-2021) 4.2 Global Lou Gehrigs Disease Sales Market Share by Type 4.3 Global Lou Gehrigs Disease Revenue Market Share by Type 4.4 Lou Gehrigs Disease Price by Type 5 Market Size by Application 5.1 Overview 5.2 Global Lou Gehrigs Disease Sales by Application 6 United States 6.1 United States Lou Gehrigs Disease Breakdown Data by Company 6.2 United States Lou Gehrigs Disease Breakdown Data by Type 6.3 United States Lou Gehrigs Disease Breakdown Data by Application 7 European Union 7.1 European Union Lou Gehrigs Disease Breakdown Data by Company 7.2 European Union Lou Gehrigs Disease Breakdown Data by Type 7.3 European Union Lou Gehrigs Disease Breakdown Data by Application 8 China 8.1 China Lou Gehrigs Disease Breakdown Data by Company 8.2 China Lou Gehrigs Disease Breakdown Data by Type 8.3 China Lou Gehrigs Disease Breakdown Data by Application 9 Rest of World 9.1 Rest of World Lou Gehrigs Disease Breakdown Data by Company 9.2 Rest of World Lou Gehrigs Disease Breakdown Data by Type 9.3 Rest of World Lou Gehrigs Disease Breakdown Data by Application 9.4 Rest of World Lou Gehrigs Disease Breakdown Data by Countries 9.4.1 Rest of World Lou Gehrigs Disease Sales by Countries 9.4.2 Rest of World Lou Gehrigs Disease Revenue by Countries 9.4.3 Japan 9.4.4 Korea 9.4.5 India 9.4.6 Southeast Asia 10 Company Profiles 10.1 AB Science 10.1.1 AB Science Company Details 10.1.2 Company Description and Business Overview 10.1.3 Sales, Revenue and Market Share of Lou Gehrigs Disease 10.1.4 Lou Gehrigs Disease Product Introduction 10.1.5 AB Science Recent Development 10.2 Avicena Group 10.2.1 Avicena Group Company Details 10.2.2 Company Description and Business Overview 10.2.3 Sales, Revenue and Market Share of Lou Gehrigs Disease 10.2.4 Lou Gehrigs Disease Product Introduction 10.2.5 Avicena Group Recent Development 10.3 Biogen 10.3.1 Biogen Company Details 10.3.2 Company Description and Business Overview 10.3.3 Sales, Revenue and Market Share of Lou Gehrigs Disease 10.3.4 Lou Gehrigs Disease Product Introduction 10.3.5 Biogen Recent Development 10.4 BrainStorm Therapeutics 10.4.1 BrainStorm Therapeutics Company Details 10.4.2 Company Description and Business Overview 10.4.3 Sales, Revenue and Market Share of Lou Gehrigs Disease 10.4.4 Lou Gehrigs Disease Product Introduction 10.4.5 BrainStorm Therapeutics Recent Development 10.5 Covis Pharmaceutical Inc. 10.5.1 Covis Pharmaceutical Inc. Company Details 10.5.2 Company Description and Business Overview 10.5.3 Sales, Revenue and Market Share of Lou Gehrigs Disease 10.5.4 Lou Gehrigs Disease Product Introduction 10.5.5 Covis Pharmaceutical Inc. Recent Development 10.6 Cytokinetics Inc. 10.6.1 Cytokinetics Inc. Company Details 10.6.2 Company Description and Business Overview 10.6.3 Sales, Revenue and Market Share of Lou Gehrigs Disease 10.6.4 Lou Gehrigs Disease Product Introduction 10.6.5 Cytokinetics Inc. Recent Development 10.7 Eisai Co. Ltd. 10.7.1 Eisai Co. Ltd. Company Details 10.7.2 Company Description and Business Overview 10.7.3 Sales, Revenue and Market Share of Lou Gehrigs Disease 10.7.4 Lou Gehrigs Disease Product Introduction 10.7.5 Eisai Co. Ltd. Recent Development 10.8 GlaxoSmithKline plc. 10.8.1 GlaxoSmithKline plc. Company Details 10.8.2 Company Description and Business Overview 10.8.3 Sales, Revenue and Market Share of Lou Gehrigs Disease 10.8.4 Lou Gehrigs Disease Product Introduction 10.8.5 GlaxoSmithKline plc. Recent Development 10.9 Ionis Pharmaceuticals, Inc. 10.9.1 Ionis Pharmaceuticals, Inc. Company Details 10.9.2 Company Description and Business Overview 10.9.3 Sales, Revenue and Market Share of Lou Gehrigs Disease 10.9.4 Lou Gehrigs Disease Product Introduction 10.9.5 Ionis Pharmaceuticals, Inc. Recent Development 10.10 Mitsubishi Tanabe Pharma Corp. 10.10.1 Mitsubishi Tanabe Pharma Corp. Company Details 10.10.2 Company Description and Business Overview 10.10.3 Sales, Revenue and Market Share of Lou Gehrigs Disease 10.10.4 Lou Gehrigs Disease Product Introduction 10.10.5 Mitsubishi Tanabe Pharma Corp. Recent Development 10.11 Neuralstem Inc. 10.12 Neuraltus Pharmaceuticals Inc. 10.13 Newron Pharmaceuticals S.p.A. 10.14 Nutra Pharma Corp. 10.15 Pharnext SAS 10.16 Q-Therapeutics Inc. 11 Value Chain and Sales Channels Analysis 11.1 Value Chain Analysis 11.2 Sales Channels Analysis 11.2.1 Lou Gehrigs Disease Sales Channels 11.2.2 Lou Gehrigs Disease Distributors 11.3 Lou Gehrigs Disease Customers 12 Market Forecast 12.1 Global Lou Gehrigs Disease Sales and Revenue Forecast 2022-2027 12.2 Global Lou Gehrigs Disease Sales Forecast by Type 12.3 Global Lou Gehrigs Disease Sales Forecast by Application 12.4 Lou Gehrigs Disease Forecast by Regions 12.4.1 Global Lou Gehrigs Disease Sales Forecast by Regions 2022-2027 12.4.2 Global Lou Gehrigs Disease Revenue Forecast by Regions 2022-2027 12.5 United States Market Forecast 12.6 European Union Market Forecast 12.7 China Market Forecast 12.8 Rest of World 12.8.1 Japan 12.8.2 Korea 12.8.3 India 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 DisclaimerList of Tables and Figures
Figure Lou Gehrigs Disease Product Picture Table Lou Gehrigs Disease Key Market Segments Table Major Manufacturers Lou Gehrigs Disease Covered in This Report Table Global Lou Gehrigs Disease Market Size Growth Rate by Type 2022-2027 (K Units) & (Million US$) Figure Global Lou Gehrigs Disease Sales Market Shar by Type 2016-2027 Figure Riluzole Figures Table Major Manufacturers of Riluzole Figure Edaravone (Radicava) Figures Table Major Manufacturers of Edaravone (Radicava) Table Global Lou Gehrigs Disease Market Share by Application 2022-2027 (K Units) Figure Hospital Pharmacies Use Case Figure Retail & Online Pharmacie Use Case Figure Lou Gehrigs Disease Report Years Considered Figure Global Lou Gehrigs Disease Market Size 2016-2027 (Million US$) Figure Global Lou Gehrigs Disease Sales 2016-2021 (K Units) Table Global Lou Gehrigs Disease Market Size by Regions 2016-2021 (K Units) & (Million US$) Table Global Lou Gehrigs Disease Sales by Regions 2016-2021 (K Units) Table Global Lou Gehrigs Disease Sales Market Share by Regions 2016-2021 Figure Global Lou Gehrigs Disease Sales Market Share by Regions 2016-2021 Figure Global Lou Gehrigs Disease Sales Market Share by Regions in 2021 Table Global Lou Gehrigs Disease Revenue by Regions 2016-2021 (Million US$) Table Global Lou Gehrigs Disease Revenue Market Share by Regions 2016-2021 Figure Global Lou Gehrigs Disease Revenue Market Share by Regions 2016-2021 Figure Global Lou Gehrigs Disease Revenue Market Share by Regions in 2021 Table Market Top Trends Table Global Lou Gehrigs Disease Sales by Manufacturers (2016-2021) (K Units) Table Global Lou Gehrigs Disease Sales Share by Manufacturers (2016-2021) Figure Global Lou Gehrigs Disease Sales Share by Manufacturers in 2021 Table Lou Gehrigs Disease Revenue by Manufacturers (2016-2021) (Million USD) Table Lou Gehrigs Disease Revenue Share by Manufacturers (2016-2021) Figure Lou Gehrigs Disease Value Share by Manufacturers in 2021 Table Global Lou Gehrigs Disease Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Manufacturers Lou Gehrigs Disease Price (2016-2021) (USD/Unit) Table Key Manufacturers Lou Gehrigs Disease Plants/Factories Distribution Table Key Manufacturers Lou Gehrigs Disease Area Served Table Date of Key Manufacturers Enter into Lou Gehrigs Disease Market Table Key Manufacturers Lou Gehrigs Disease Product Type Table Mergers & Acquisitions, Expansion Plans Table Global Riluzole Sales and Revenue (2016-2021) (K Units) & (Million US$) Table Global Edaravone (Radicava) Sales and Revenue (2016-2021) (K Units) & (Million US$) Table Global Lou Gehrigs Disease Sales by Type (2016-2021) (K Units) Table Global Lou Gehrigs Disease Sales Share by Type (2016-2021) Figure Global Lou Gehrigs Disease Sales Market Share by Type (2016-2021) Figure Global Lou Gehrigs Disease Sales Market Share by Type in 2021 Table Global Lou Gehrigs Disease Revenue by Type (2016-2021) (Million US$) Table Global Lou Gehrigs Disease Revenue Share by Type (2016-2021) Figure Global Lou Gehrigs Disease Revenue Market Share by Type (2016-2021) Figure Global Lou Gehrigs Disease Revenue Market Share by Type in 2021 Table Lou Gehrigs Disease Price by Type 2016-2021 (USD/Unit) Table Global Lou Gehrigs Disease Sales by Application (2016-2021) (K Units) Table Global Lou Gehrigs Disease Sales Share by Application (2016-2021) Figure Global Sales Lou Gehrigs Disease Market Share by Application (2016-2021) Figure Global Sales Lou Gehrigs Disease Market Share by Application (2016-2021) Figure United States Lou Gehrigs Disease Sales Growth Rate 2016-2021 (K Units) Figure United States Lou Gehrigs Disease Revenue Growth Rate 2016-2021 (Million US$) Table United States Lou Gehrigs Disease Sales by Company (2016-2021) (K Units) Table United States Lou Gehrigs Disease Sales Market Share by Company (2016-2021) Figure United States Lou Gehrigs Disease Sales Market Share by Company in 2021 Table United States Lou Gehrigs Disease Sales by Type (2016-2021) (K Units) Table United States Lou Gehrigs Disease Sales Market Share by Type (2016-2021) Figure United States Lou Gehrigs Disease Market Share by Type in 2021 Table United States Lou Gehrigs Disease Sales by Application (2016-2021) (K Units) Table United States Lou Gehrigs Disease Sales Market Share by Application (2016-2021) Figure United States Lou Gehrigs Disease Market Share by Application in 2021 Figure European Union Lou Gehrigs Disease Sales Growth Rate 2016-2021 (K Units) Figure European Union Lou Gehrigs Disease Revenue Growth Rate 2016-2021 (Million US$) Table European Union Lou Gehrigs Disease Sales by Company (2016-2021) (K Units) Table European Union Lou Gehrigs Disease Sales Market Share by Company (2016-2021) Figure European Union Lou Gehrigs Disease Sales Market Share by Company in 2021 Table European Union Lou Gehrigs Disease Sales by Type (2016-2021) (K Units) Table European Union Lou Gehrigs Disease Sales Market Share by Type (2016-2021) Figure European Union Lou Gehrigs Disease Market Share by Type Table European Union Lou Gehrigs Disease Sales by Application (2016-2021) (K Units) Table European Union Lou Gehrigs Disease Sales Market Share by Application (2016-2021) Figure European Union Lou Gehrigs Disease Market Share by Application Figure China Lou Gehrigs Disease Sales Growth Rate 2016-2021 (K Units) Figure China Lou Gehrigs Disease Revenue Growth Rate 2016-2021 (Million US$) Table China Lou Gehrigs Disease Sales by Company (2016-2021) (K Units) Table China Lou Gehrigs Disease Sales Market Share by Company (2016-2021) Figure China Lou Gehrigs Disease Sales Market Share by Company in 2021 Table China Lou Gehrigs Disease Sales by Type (2016-2021) (K Units) Table China Lou Gehrigs Disease Sales Market Share by Type (2016-2021) Figure China Lou Gehrigs Disease Market Share by Type in 2021 Table China Lou Gehrigs Disease Sales by Application (2016-2021) (K Units) Table China Lou Gehrigs Disease Sales Market Share by Application (2016-2021) Figure China Lou Gehrigs Disease Market Share by Application in 2021 Figure Rest of World Lou Gehrigs Disease Sales Growth Rate 2016-2021 (K Units) Figure Rest of World Lou Gehrigs Disease Revenue Growth Rate 2016-2021 (Million US$) Table Rest of World Lou Gehrigs Disease Sales by Company (2016-2021) (K Units) Table Rest of World Lou Gehrigs Disease Sales Market Share by Company (2016-2021) Figure Rest of World Lou Gehrigs Disease Sales Market Share by Company in 2021 Table Rest of World Lou Gehrigs Disease Sales by Type (2016-2021) (K Units) Table Rest of World Lou Gehrigs Disease Sales Market Share by Type (2016-2021) Figure Rest of World Lou Gehrigs Disease Market Share by Type in 2021 Table Rest of World Lou Gehrigs Disease Sales by Application (2016-2021) (K Units) Table Rest of World Lou Gehrigs Disease Sales Market Share by Application (2016-2021) Figure Rest of World Lou Gehrigs Disease Market Share by Application in 2021 Table Rest of World Lou Gehrigs Disease Sales by Countries (2016-2021) (K Units) Table Rest of World Lou Gehrigs Disease Sales Market Share by Countries (2016-2021) Figure Rest of World Lou Gehrigs Disease Sales Market Share by Countries in 2021 Table Rest of World Lou Gehrigs Disease Revenue by Countries (2016-2021) (Million US$) Table Rest of World Lou Gehrigs Disease Revenue Market Share by Countries (2016-2021) Figure Rest of World Lou Gehrigs Disease Revenue Market Share by Countries in 2021 Figure Japan Lou Gehrigs Disease Sales Growth Rate (2016-2021) (K Units) Figure Japan Lou Gehrigs Disease Revenue Growth Rate (2016-2021) (K Units) Figure Korea Lou Gehrigs Disease Sales Growth Rate (2016-2021) (K Units) Figure Korea Lou Gehrigs Disease Revenue Growth Rate (2016-2021) (K Units) Figure India Lou Gehrigs Disease Sales Growth Rate (2016-2021) (K Units) Figure India Lou Gehrigs Disease Revenue Growth Rate (2016-2021) (K Units) Figure Southeast Asia Lou Gehrigs Disease Sales Growth Rate (2016-2021) (K Units) Figure Southeast Asia Lou Gehrigs Disease Revenue Growth Rate (2016-2021) (K Units) Table AB Science Company Details Table AB Science Description and Business Overview Table AB Science Lou Gehrigs Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table AB Science Lou Gehrigs Disease Sales Growth Rate (2016-2021) Table AB Science Lou Gehrigs Disease Sales Market Share in Global Market Table AB Science Recent Development Table Avicena Group Company Details Table Avicena Group Description and Business Overview Table Avicena Group Lou Gehrigs Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table Avicena Group Lou Gehrigs Disease Sales Growth Rate (2016-2021) Table Avicena Group Lou Gehrigs Disease Sales Market Share in Global Market Table Avicena Group Recent Development Table Biogen Company Details Table Biogen Description and Business Overview Table Biogen Lou Gehrigs Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table Biogen Lou Gehrigs Disease Sales Growth Rate (2016-2021) Table Biogen Lou Gehrigs Disease Sales Market Share in Global Market Table Biogen Recent Development Table BrainStorm Therapeutics Company Details Table BrainStorm Therapeutics Description and Business Overview Table BrainStorm Therapeutics Lou Gehrigs Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table BrainStorm Therapeutics Lou Gehrigs Disease Sales Growth Rate (2016-2021) Table BrainStorm Therapeutics Lou Gehrigs Disease Sales Market Share in Global Market Table BrainStorm Therapeutics Recent Development Table Covis Pharmaceutical Inc. Company Details Table Covis Pharmaceutical Inc. Description and Business Overview Table Covis Pharmaceutical Inc. Lou Gehrigs Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table Covis Pharmaceutical Inc. Lou Gehrigs Disease Sales Growth Rate (2016-2021) Table Covis Pharmaceutical Inc. Lou Gehrigs Disease Sales Market Share in Global Market Table Covis Pharmaceutical Inc. Recent Development Table Cytokinetics Inc. Company Details Table Cytokinetics Inc. Description and Business Overview Table Cytokinetics Inc. Lou Gehrigs Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table Cytokinetics Inc. Lou Gehrigs Disease Sales Growth Rate (2016-2021) Table Cytokinetics Inc. Lou Gehrigs Disease Sales Market Share in Global Market Table Cytokinetics Inc. Recent Development Table Eisai Co. Ltd. Company Details Table Eisai Co. Ltd. Description and Business Overview Table Eisai Co. Ltd. Lou Gehrigs Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table Eisai Co. Ltd. Lou Gehrigs Disease Sales Growth Rate (2016-2021) Table Eisai Co. Ltd. Lou Gehrigs Disease Sales Market Share in Global Market Table Eisai Co. Ltd. Recent Development Table GlaxoSmithKline plc. Company Details Table GlaxoSmithKline plc. Description and Business Overview Table GlaxoSmithKline plc. Lou Gehrigs Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table GlaxoSmithKline plc. Lou Gehrigs Disease Sales Growth Rate (2016-2021) Table GlaxoSmithKline plc. Lou Gehrigs Disease Sales Market Share in Global Market Table GlaxoSmithKline plc. Recent Development Table Ionis Pharmaceuticals, Inc. Company Details Table Ionis Pharmaceuticals, Inc. Description and Business Overview Table Ionis Pharmaceuticals, Inc. Lou Gehrigs Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table Ionis Pharmaceuticals, Inc. Lou Gehrigs Disease Sales Growth Rate (2016-2021) Table Ionis Pharmaceuticals, Inc. Lou Gehrigs Disease Sales Market Share in Global Market Table Ionis Pharmaceuticals, Inc. Recent Development Table Mitsubishi Tanabe Pharma Corp. Company Details Table Mitsubishi Tanabe Pharma Corp. Description and Business Overview Table Mitsubishi Tanabe Pharma Corp. Lou Gehrigs Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table Mitsubishi Tanabe Pharma Corp. Lou Gehrigs Disease Sales Growth Rate (2016-2021) Table Mitsubishi Tanabe Pharma Corp. Lou Gehrigs Disease Sales Market Share in Global Market Table Mitsubishi Tanabe Pharma Corp. Recent Development Table Neuralstem Inc. Company Details Table Neuraltus Pharmaceuticals Inc. Company Details Table Newron Pharmaceuticals S.p.A. Company Details Table Nutra Pharma Corp. Company Details Table Pharnext SAS Company Details Table Q-Therapeutics Inc. Company Details Figure Lou Gehrigs Disease Value Chain Table Lou Gehrigs Disease Distributors List Table Lou Gehrigs Disease Customers List Table Global Lou Gehrigs Disease Sales Forecast 2022-2027 (K Units) & (Million US$) Figure Global Lou Gehrigs Disease Sales Forecast 2022-2027 (K Units) Figure Global Lou Gehrigs Disease Revenue Forecast 2022-2027 (Million US$) Table Global Lou Gehrigs Disease Sales Forecast by Type 2022-2027 (K Units) Figure Global Lou Gehrigs Disease Sales Forecast by Type 2022-2027 (K Units) Figure Global Lou Gehrigs Disease Sales Market Share Forecast by Type 2022-2027 Table Global Lou Gehrigs Disease Sales Forecast by Application 2022-2027 (K Units) Figure Global Lou Gehrigs Disease Sales Forecast by Application 2022-2027 (K Units) Figure Global Lou Gehrigs Disease Sales Market Share Forecast by Application 2022-2027 Table Global Lou Gehrigs Disease Sales Forecast by Regions 2022-2027 (K Units) Figure Global Lou Gehrigs Disease Sales Forecast by Regions 2022-2027 (K Units) Figure Global Lou Gehrigs Disease Sales Market Share Forecast by Regions 2022-2027 Table Global Lou Gehrigs Disease Revenue Forecast by Regions 2022-2027 (K Units) Figure Global Lou Gehrigs Disease Revenue Forecast by Regions 2022-2027 (K Units) Figure Global Lou Gehrigs Disease Revenue Market Share Forecast by Regions 2022-2027 Figure United States Lou Gehrigs Disease Sales Forecast 2022-2027 (K Units) Figure United States Lou Gehrigs Disease Revenue Forecast 2022-2027 (Million US$) Figure European Union Lou Gehrigs Disease Sales Forecast 2022-2027 (K Units) Figure European Union Lou Gehrigs Disease Revenue Forecast 2022-2027 (Million US$) Figure China Lou Gehrigs Disease Sales Forecast 2022-2027 (K Units) Figure China Lou Gehrigs Disease Revenue Forecast 2022-2027 (Million US$) Figure Japan Lou Gehrigs Disease Sales Forecast 2022-2027 (K Units) Figure Japan Lou Gehrigs Disease Revenue Forecast 2022-2027 (Million US$) Figure Korea Lou Gehrigs Disease Sales Forecast 2022-2027 (K Units) Figure Korea Lou Gehrigs Disease Revenue Forecast 2022-2027 (Million US$) Figure India Lou Gehrigs Disease Sales Forecast 2022-2027 (K Units) Figure India Lou Gehrigs Disease Revenue Forecast 2022-2027 (Million US$) Figure Southeast Asia Lou Gehrigs Disease Sales Forecast 2022-2027 (K Units) Figure Southeast Asia Lou Gehrigs Disease Revenue Forecast 2022-2027 (Million US$) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources